31 min listen
Teprotumumab and Thyroid Eye Disease
FromExperts InSight
ratings:
Length:
30 minutes
Released:
Dec 31, 2021
Format:
Podcast episode
Description
Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Released:
Dec 31, 2021
Format:
Podcast episode
Titles in the series (67)
How to Approach the Uveitis Patient, Front to Back: Drs. Jessica Shantha and Brian Do offer a crash course on how to methodically assess the uveitis patient, moving from the front of the eye to the back to diagnose anterior, intermediate, posterior, and panuveitis. For all episodes or to claim CME... by Experts InSight